Integrated Diagnostics (LON:IDHC) Sets New 1-Year High – Still a Buy?

Integrated Diagnostics Holdings plc (LON:IDHC)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 0.73 and last traded at GBX 0.73, with a volume of 71006 shares traded. The stock had previously closed at GBX 0.70.

Integrated Diagnostics Trading Up 4.3%

The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 45.72. The business has a fifty day moving average price of GBX 0.63 and a 200 day moving average price of GBX 0.50. The company has a market capitalization of £4.24 million, a P/E ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.59.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.